Literature DB >> 22405857

Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation.

Jean-Hugues Salmon1, Guillaume Direz, Jean-Marc Ziza, Nicole Desplaces, Pascal Brochot, Jean-Paul Eschard.   

Abstract

A patient was diagnosed with discitis and sacroiliitis due to Mycobacterium xenopi. He had a history of percutaneous nucleotomy performed 15 years earlier (in 1992) at the Clinique du Sport, Paris, France, during an outbreak of nosocomial M. xenopi infection at that institution. In 1997, magnetic resonance imaging performed as part of the routine follow-up program for patients who had surgery at the Clinique du Sport during the outbreak was not interpreted as indicating discitis; this assessment was confirmed by our review of the images. Bone and joint infections due to atypical mycobacteria are rare and can develop very slowly. To our knowledge, this is the first reported case of M. xenopi discitis with secondary extension to the sacroiliac joint in an immunocompetent patient.
Copyright © 2012 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22405857     DOI: 10.1016/j.jbspin.2012.02.001

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  2 in total

1.  Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media.

Authors:  Caroline Leyer; Guillaume Gregorowicz; Faiza Mougari; Laurent Raskine; Emmanuelle Cambau; Dominique de Briel
Journal:  J Clin Microbiol       Date:  2017-04-19       Impact factor: 5.948

Review 2.  Prosthetic joint infection due to Mycobacterium xenopi: a review of the literature with a new case report.

Authors:  Paola Rodari; Stefania Marocco; Dora Buonfrate; Anna Beltrame; Chiara Piubelli; Pierantonio Orza; Veronica Andrea Fittipaldo; Zeno Bisoffi
Journal:  Infection       Date:  2019-05-16       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.